NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
NEPHROS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$3.68+0.03 (+0.82%)
Close on Oct 19, 2026
- Market cap
- $40.89M
- P/E (TTM)
- 23.0
- Dividend yield
- –
Share price
−$1.21 (−24.74%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
NEPHROS INC grew revenue 24.2% to $20.72M over the twelve months to Jun 30, 2026. Operating income rose 22.8% to $1.64M, moving the operating margin from 8.0% to 7.9%.
Revenue
$20.72M
+24.2% vs. a year earlier
Operating income
$1.64M
+22.8% vs. a year earlier
EPS, diluted
$0.16
+33.3% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $40.89M
- P/E ratio
- 23.0
- Price to sales
- 1.97
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $20.72M
- Net income
- $1.74M
- EPS, diluted
- $0.16
- Diluted shares
- 11M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$20.72M+24.2% YoY
Gross profit
$12.70M+20.1% YoY
Operating income
$1.64M+22.8% YoY
Net income
$1.74M+30.8% YoY
EPS, diluted
$0.16+33.3% YoY
Free cash flow
–
Reported periodTrailing twelve months